Joint Bone Spine: Volume 88 (Issue 1 to Issue 6)
Bimonthly e-only international journal, Joint Bone Spine publishes in English original research articles and all the latest advances that deal with disorders affecting the joints, bones, and spine and, more generally, the entire field of rheumatology and rheumatic diseases.
All submitted manuscripts to the journal are subjected to rigorous peer review by international experts: under no circumstances does the journal guarantee publication before the editorial board makes its final decision. (Surgical techniques and work focusing specifically on orthopedic surgery are not within the scope of the journal.) Joint Bone Spine is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms. Please note: Few articles published by Joint Bone Spine may be also translated for publication in French in the Revue du Rhumatisme (editor’s choice), the official publication of the French Society of Rheumatology (SFR).
– Volume 88, Issue 1: January 2021
– Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
This supplement was published with institutional funding provided by AbbVie, Amgen, Biogen, Celltrion, Fresenius Kabi, MSD, Mylan, Pfizer, Sandoz and UCB.
Volume 88, Issue 2, Supplement 1,
May 2021
– Volume 88, Issue 2: March 2021
– Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
This supplement was published with institutional funding provided by Lilly and Novartis.
Volume 88, Issue 3, Supplement 1,
May 2021
– Volume 88, Issue 3: May 2021
– Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
This supplement was published with support from the Club Rhumatismes et Inflammation (CRI).
Volume 88, Issue 4, Supplement 1,
June 2021
– Volume 88, Issue 4: July 2021
– Practical management of patients on hydroxychloroquine
This supplement was produced in partnership with FAI2R, SFR, SNFMI, SFD, and SOFREMIP, under the aegis of CRI.
Volume 88, Issue 5, Supplement 1,
December 2021
– Volume 88, Issue 5: October 2021
– Volume 88, Issue 6: December 2021
Reviews
There are no reviews yet.